Home
iDEXIS Compounding

iDEXIS Compounding Market Share Analysis for July 2026

Health > Alternative and Natural Medicine

Domainidexis.co.za

Year Founded2014

Employees51 - 200

Annual Revenue--

iDEXIS Compounding

iDEXIS Compounding (including company regionals)

idexis.co.za

See more website traffic and engagement information

Total visits to iDEXIS Compounding's top domains

Understand iDEXIS Compounding market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

idexis.co.za15.8K

See more with Sales Intelligence

Avg. visit duration in iDEXIS Compounding's top domains

Analyze iDEXIS Compounding engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

idexis.co.za00:05:17

See more with Sales Intelligence

Avg. pageviews on iDEXIS Compounding's top domains

See how iDEXIS Compounding keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

idexis.co.za5.08

See more with Sales Intelligence

iDEXIS Compounding top competitors by domain

Top similar sites in July 2026, ranked by their affinity

balans.co.zaCompany NameBalansEmployees201 - 500HQUnited Kingdom, WestfieldAnnual revenue$2M - $5MTotal visits6.2KN/A

Top technologies used by iDEXIS Compounding

These are the website technologies, by industry, used by iDEXIS Compounding top domains

Widget (6)

Twemoji

Social (3)

Instagram

Content Management System (2)

WordPress

Email Services (2)

Sendgrid

More Technologies

8

See all

News & Signals from iDEXIS Compounding

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNovo Nordisk A/S filed suit against Idexis on Jun 1st '26.The warning follows a High Court interim order granted last month barring iDexis from manufacturing and selling medicines containing semaglutide, in a case brought by Novo Nordisk.

NewsIdexis had issues with illegally manufacturing and selling unregistered semaglutide products and competing in South Africa's fast-growing weight-loss market without complying with medicines regulations on Jun 1st '26.The Danish drugmaker argued that iDexis was illegally manufacturing and selling unregistered semaglutide products and competing in South Africa's fast-growing weight-loss market without complying with medicines regulations.

NewsIdexis had issues with producing unauthorized copies of semaglutide on Jun 10th '26.Novo Nordisk has on Wednesday sued the South African pharmacy Idexis in court for producing unauthorized copies of semaglutide.